Expanded Access to Velmanase Alfa

Brief Title

Expanded Access to Velmanase Alfa


Brief Summary

      Individual patient expanded access requests may be considered for patients who have no other
      treatment options.
    

Detailed Description

      Expanded access may provide access for treatment prior to approval by the local regulatory
      agency.
    


Study Type

Expanded Access




Condition

Alpha-Mannosidosis

Intervention

Velmanase Alfa


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Drug





Eligibility Criteria

        Inclusion Criteria:

        -

        Exclusion Criteria:

        -
      

Gender

All

Ages

N/A - N/A


Contacts

, (888) 661-9260, [email protected]



Administrative Informations


NCT ID

NCT04959240

Organization ID

Velmanase alfa-EAP


Responsible Party

Sponsor

Study Sponsor

Chiesi Farmaceutici S.p.A.


Study Sponsor

, , 


Verification Date

July 2021